BIOFIRE® Respiratory 2.1 (RP2.1) Panel
The BIOFIRE® RP2.1 Panel helps clinicians quickly diagnose respiratory tract infections by detecting pathogens like SARS-CoV-2, influenza, RSV, and many others.
Receive your quote directly from the manufacturer.
Great result
Respiratory pathogens
Easy fast and efficient
Review Date: 27 Jun 2023 | bioMérieux
Every lab should have this test offered!
Analysis of nasopharyngeal swab for the detection of relevant respiratory tract pathogen.
The Biofire Respiratory Panel 2.1 is a one stop test for all the relevant respiratory tract pathogen. It is quick, easy to use, and accurate!
Review Date: 17 Apr 2023 | bioMérieux
Easy setup and fast TAT!
Patient testing in hospital environment.
The BioFire Filmarray products are easy to use and each kit is standardized. If you know how to set up one type you pretty much know how to set up most of them. I do wish the kits came preassembled in easy grab and go pouches with one of each reagent and such in them instead of separated in big bags. Repeated opening/closing of the bags and hands in and out increases the risk of contamination. So, packaging could be simplified and streamlined, but otherwise we are very happy with the products.
Review Date: 17 Apr 2023 | bioMérieux
Quality and speed make this an invaluable test offering for our patients and doctors.
Molecular diagnostics
The respiratory panel 2 enables us to detect various pathogens aside from SARS-cov-2 in cases of pneumonia, to quickly identify treatable etiology / agents. After -sales service is prompt and efficient. Although it costs more, it is worth it due to rapid results enabling timely life-saving intervention by clinicians.
Review Date: 15 Jun 2021 | bioMérieux
Great results within a couple of hours.
Respiratory infection diagnosis
The product provides easy and quick test for common respiratory microorganisms. It does not need to wait for multiple samples to run together so that TNT of the assay is much reduced.
Review Date: 15 Jun 2021 | bioMérieux
Effective and conclusive diagnosis can't be achieved without this testing kit.
Diagnosis
It gives a wide range of diagnosis for viruses and bacteria.
Review Date: 15 Jun 2021 | bioMérieux
Excellent machine
Molecular
Very good
Review Date: 15 Jun 2021 | bioMérieux
Great!
Covid
Excellent product. Very useful for ER patients with respiratory profile.
Review Date: 6 Jun 2021 | bioMérieux
With Biofire, no need to guess, just know.
Syndromic testing for respiratory patients
It helps to accelerate the workflow to get a quick answer in order to help the patient, all we need is the sample without any preparation. Takes 45 mins to get an accurate and comprehensive result. Since respiratory symptoms are often the same we need such a panel to reduce the patient length of stay and reduce the number of tests needed. Also the fast response from the Biofire team for any concerns is an advantage.
Review Date: 25 May 2021 | bioMérieux
Excellent instrument and product. Zero communication with users.
Molecular microbiology
Very bad communication between account manager and clients.
Review Date: 8 Feb 2021 | bioMérieux
Quick turnaround on a broad menu of pathogens helps clinicians make vital decisions regarding admission, isolation, cohorting, and additional diagnostic testing.
The BIOFIRE® RP2.1 Panel uses a syndromic approach to accurately detect and identify the pathogens most commonly associated with respiratory infections.
Results are available in about 45 minutes.
Available for use on the BIOFIRE® FILMARRAY® TORCH System.
Bridging pandemic-associated antimicrobial stewardship gaps with diagnostics
Join Brian Raux, Medical Science Liaison at bioMérieux, in this webinar as he discusses the gaps in antimicrobial stewardship programs caused by the COVID-19 pandemic and how diagnostics can be leveraged to bridge those gaps.
During the webinar, Raux will cover how antimicrobial resistance has changed during the pandemic and how institutions can locally track and use their data. Raux will also explore the impact staffing shortages have had on the microbiology lab and how utilizing the syndromic approach can enable labs to do more with less.
Key learning objectives
- Realize the impact of rapid molecular diagnostics on antibiotic use
- Understand local antibiograms and growing resistance
- Explore the impact of syndromic testing and how it can address workforce shortages
Who should attend?
- Lab professionals: directors, supervisors, techs, etc. Clinicians, Pharmacists
Certificate of attendance
All webinar participants can request a certificate of attendance, including a learning outcomes summary, for continuing education purposes.
Rapid diagnostics combat unnecessary antimicrobial use in pulmonary disease management
Discover how a rapid diagnosis between viral and bacterial pulmonary infections can minimize antibiotic usage in critical care
Accelerating science with technology: The hero lab products you can’t live without
To recognize 25 years of accelerating science, we’re highlighting reviews on innovative technologies and your laboratory essentials
6 articles to expand your understanding of syndromic testing
Gain insight into how syndromic testing can improve pathogen detection, lead to better-informed treatment plans, and aid antimicrobial stewardship
Pneumonia diagnosis & management: Is this the new standard of care?
Discover a rapid, sensitive, and comprehensive diagnostic testing method with improved antimicrobial stewardship
The role of syndromic testing in the era of COVID-19
Syndromic testing: A powerful approach for simultaneous pathogen detection
Find out how to rapidly test for multiple disease-causing microorganisms with syndromic panel-based testing
![VIDAS® NEPHROCHECK® [TIMP-2 · IGFBP-7] - bioMérieux USA - Clinical Diagnostics](https://cdn.sanity.io/images/f5b6mtfn/selectscience-prod/b460faac10fbdbdd33c0576d81d57cd8ef744cdc-75x75.jpg?w=3840&q=75&fit=clip&auto=format)